Irritable Bowel Syndrome

Disease State Hub

From the Journal

GI Disorders

Irritable Bowel Syndrome: Rational Therapy

04/28/2011

Nicholas J. Talley, MD, PhD, FRACP

Irritable bowel syndrome is characterized by abdominal pain or discomfort, bloating, and constipation or diarrhea; the pain is typically relieved by defecation.

04/28/2011

Research Summaries

guidelines

AGA Updates IBS-D Guidelines

07/15/2022

The American Gastroenterological Association has updated its guidelines on the management of irritable bowel syndrome with diarrhea.

07/15/2022

Exocrine Pancreatic Insufficiency

Undiagnosed EPI May Be Prevalent in Individuals With IBS-D

06/29/2022

Researchers examined the presence of undiagnosed severe exocrine pancreatic insufficiency in individuals with irritable bowel syndrome plus diarrhea, as well as the associated symptoms and the impact of...

06/29/2022

Gastrointestinal Disorders

Campylobacter Infection May Increase Risk of Irritable Bowel Syndrome

10/16/2019

The authors of a new study evaluated more than 4000 cases of Campylobacter infection to estimate the US incidence of Campylobacter infection–associated postinfectious irritable bowel syndrome.

10/16/2019

FDA

FDA Approves New Treatment for IBS-C

09/13/2019

The NHE3 sodium transport inhibitor was approved for use after results from 2 clinical trials showed increased bowel movements and decreased abdominal pain among individuals with IBS-C.

09/13/2019

IBS

FDA Allows Marketing of Medical Device for the Treatment of IBS in Adolescents

06/10/2019

After a clinical trial showed the device was more effective than placebo, the FDA permitted marketing for the medical device that assists in the reduction of functional abdominal pain among adolescents with...

06/10/2019

November 2024

Current Issue

November 2024